All Phenotypes Dsg2<tm1d(EUCOMM)Wtsi> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2^{tm1d(EUCOMM)Wtsi}	involves: C57BL/6J * C57BL/6N	MGI:6501726
ht2	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2⁺	involves: C57BL/6J * C57BL/6N	MGI:6501758
cx3	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2^{tm1d(EUCOMM)Wtsi} Gsk3b^tm1Dral/Gsk3b^tm1Dral	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N	MGI:6501734
cx4	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2^{tm1d(EUCOMM)Wtsi} Gsk3b^tm1Dral/Gsk3b⁺	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N	MGI:6501735
cx5	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2⁺ Gsk3b^tm1Dral/Gsk3b⁺	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N	MGI:6501755
cx6	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2⁺ Gsk3b^tm1Dral/Gsk3b^tm1Dral	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N	MGI:6501756

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

cardiac fibrosis ( J:235770 )

• extensive biventricular epicardial and endocardial fibrosis

• exercised mice show extensive biventricular fibrosis

• mice treated daily with the GSK3B inhibitor SB216763 at 3 weeks of age do not exhibit biventricular epicardial and endocardial fibrosis

decreased cardiac muscle contractility ( J:235770 )

• mice show reduced ejection fraction and fractional shortening by 8 weeks of age

• exercised mice show reduced ejection fraction and fractional shortening compared to exercised wild-type mice

• SB216763 treatment improves cardiac function

abnormal heart echocardiography feature ( J:235770 )

• echocardiography shows reduced interventricular septal end-systolic volume, increased left ventricular internal diameter end-diastolic volume and end-systolic volume, decreased left ventricular posterior wall end systole, and reduced fractional shortening and ejection fraction

ventricular premature beat ( J:235770 )

• mice show increased ventricular ectopy

decreased P wave amplitude ( J:235770 )

increased Q wave amplitude ( J:235770 )

prolonged QRS complex duration ( J:235770 )

• prolongation of the average QRS duration

• exercised mice show longer mean QRS complex duration than exercised wild-type mice

• SB216763 treatment normalizes QRS duration

abnormal S wave ( J:235770 )

• mice show reduced S wave amplitude

• exercised mice show reduced S wave amplitude

increased cardiomyocyte apoptosis ( J:235770 )

• exercised mice show numerous TUNEL+ nuclei in the myocardium indicating increased apoptosis compared to exercised wild-type mice

cardiomyopathy ( J:235770 )

• mice develop cardiomyopathy by 8 weeks of age

heart inflammation ( J:235770 )

• biventricular and endocardial inflammation

• exercised mice show extensive biventricular fibrosis and inflammation

• mice treated daily with SB216763 at 3 weeks of age do not exhibit biventricular epicardial and endocardial fibrosis inflammation

mortality/aging

increased susceptibility to induced morbidity/mortality ( J:235770 )

• 55% of mice die while swimming, with mean time of exercise at death of 7.8 +/- 0.6 weeks

• SB216763 treatment improves survival of exercised mice

immune system

heart inflammation ( J:235770 )

• biventricular and endocardial inflammation

• exercised mice show extensive biventricular fibrosis and inflammation

• mice treated daily with SB216763 at 3 weeks of age do not exhibit biventricular epicardial and endocardial fibrosis inflammation

muscle

decreased cardiac muscle contractility ( J:235770 )

• mice show reduced ejection fraction and fractional shortening by 8 weeks of age

• exercised mice show reduced ejection fraction and fractional shortening compared to exercised wild-type mice

• SB216763 treatment improves cardiac function

increased cardiomyocyte apoptosis ( J:235770 )

• exercised mice show numerous TUNEL+ nuclei in the myocardium indicating increased apoptosis compared to exercised wild-type mice

cardiomyopathy ( J:235770 )

• mice develop cardiomyopathy by 8 weeks of age

cellular

increased cardiomyocyte apoptosis ( J:235770 )

• exercised mice show numerous TUNEL+ nuclei in the myocardium indicating increased apoptosis compared to exercised wild-type mice

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
arrhythmogenic right ventricular dysplasia 10		DOID:0110081	OMIM:610193	J:235770

Allelic Composition	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2⁺
Genetic Background	involves: C57BL/6J * C57BL/6N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dsg2^{tm1d(EUCOMM)Wtsi} mutation (0 available); any Dsg2 mutation (79 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

cardiovascular system phenotype ( J:235770 )

N	• mice show normal cardiac function and histology at rest

abnormal heart electrocardiography waveform feature ( J:235770 )

• mice show abnormal ECG readings in response to exercise

Allelic Composition	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2^{tm1d(EUCOMM)Wtsi} Gsk3b^tm1Dral/Gsk3b^tm1Dral
Genetic Background	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dsg2^{tm1d(EUCOMM)Wtsi} mutation (0 available); any Dsg2 mutation (79 available)
Gsk3b^tm1Dral mutation (1 available); any Gsk3b mutation (111 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

cardiac fibrosis ( J:235770 )

• hearts show extensive biventricular fibrosis

decreased cardiac muscle contractility ( J:235770 )

• echocardiography shows reduced cardiac function by 8-16 weeks of age, with reduced ejection fraction and fractional shortening

prolonged PR interval ( J:235770 )

increased Q wave amplitude ( J:235770 )

prolonged QRS complex duration ( J:235770 )

abnormal S wave ( J:235770 )

• reduced S-wave amplitude

muscle

decreased cardiac muscle contractility ( J:235770 )

• echocardiography shows reduced cardiac function by 8-16 weeks of age, with reduced ejection fraction and fractional shortening

Allelic Composition	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2^{tm1d(EUCOMM)Wtsi} Gsk3b^tm1Dral/Gsk3b⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

cardiac fibrosis ( J:235770 )

• hearts show extensive biventricular fibrosis

decreased cardiac muscle contractility ( J:235770 )

• echocardiography shows reduced cardiac function by 8-16 weeks of age, with reduced ejection fraction and fractional shortening

prolonged PR interval ( J:235770 )

prolonged QRS complex duration ( J:235770 )

abnormal S wave ( J:235770 )

• reduced S-wave amplitude

muscle

decreased cardiac muscle contractility ( J:235770 )

• echocardiography shows reduced cardiac function by 8-16 weeks of age, with reduced ejection fraction and fractional shortening

Allelic Composition	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2⁺ Gsk3b^tm1Dral/Gsk3b⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

abnormal heart electrocardiography waveform feature ( J:235770 )

• mice exhibit nearly normal cardiac function at 16 weeks of age, although subtle ECG abnormalities are seen

prolonged PR interval ( J:235770 )

prolonged QRS complex duration ( J:235770 )

Allelic Composition	Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2⁺ Gsk3b^tm1Dral/Gsk3b^tm1Dral
Genetic Background	involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

abnormal heart electrocardiography waveform feature ( J:235770 )

prolonged PR interval ( J:235770 )

prolonged QRS complex duration ( J:235770 )

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 05/07/2024 MGI 6.23